Biosenta Inc. reported earnings results for the second quarter and six months ended March 31, 2023. For the second quarter, the company reported sales was CAD 0.000175 million. Net loss was CAD 0.33677 million compared to CAD 2.15 million a year ago. Basic loss per share from continuing operations was CAD 0.01 compared to CAD 0.11 a year ago.
For the six months, sales was CAD 0.000468 million compared to CAD 0.000292 million a year ago. Net loss was CAD 0.578613 million compared to CAD 2.7 million a year ago. Basic loss per share from continuing operations was CAD 0.03 compared to CAD 0.14 a year ago.